Acadia pharmaceuticals appoints thomas garner chief commercial officer

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that thomas andrew garner has been appointed chief commercial officer, effective today. mr. garner will spearhead acadia's commercial strategy and operations, driving the company's plans for sustained growth and expansion of its product portfolio and pipeline across u.s. and international markets. mr. garner will report to catherine owen adams, acadia's ceo, and serve on the executive leadership team. “tom is.
ACAD Ratings Summary
ACAD Quant Ranking